Comparing Medical Utilization and Cost Outcomes in Oral Versus Injectable Immunotherapy Users with Chronic Inflammatory Joint and Skin Diseases

BACKGROUND: Rheumatoid arthritis (RA), psoriatic arthritis (PsA), and psoriasis (PSO) are immune-mediated systemic, chronic inflammatory conditions. Moderate to severe disease is treated with conventional disease-modifying antirheumatic drugs (DMARDs) such as methotrexate, sulfasalazine, or leflunom...

Descripción completa

Detalles Bibliográficos
Autores principales: Bhattacharya, Rituparna, Herren, Katie, Poonawalla, Insiya, Bunniran, Suvapun, Bloomfield, Andrea, Schwab, Phil
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Academy of Managed Care Pharmacy 2020
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10391197/
https://www.ncbi.nlm.nih.gov/pubmed/32996385
http://dx.doi.org/10.18553/jmcp.2020.26.10.1246

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10391197/
https://www.ncbi.nlm.nih.gov/pubmed/32996385
http://dx.doi.org/10.18553/jmcp.2020.26.10.1246

Ejemplares similares